XML 23 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2017
Dec. 31, 2016
Current Assets:    
Cash and cash equivalents $ 524.4 $ 634.1
Accounts receivable, less allowance for doubtful accounts 1,494.6 1,604.4
Inventories 2,081.8 1,959.4
Prepaid expenses and other current assets 414.5 465.7
Total Current Assets 4,515.3 4,663.6
Property, plant and equipment, net 2,038.6 2,037.9
Goodwill 10,668.4 10,643.9
Intangible assets, net 8,353.4 8,785.4
Other assets 388.8 553.6
Total Assets 25,964.5 26,684.4
Current Liabilities:    
Accounts payable 330.2 364.5
Income taxes payable 165.2 183.5
Other current liabilities 1,299.8 1,257.9
Current portion of long-term debt 1,225.0 575.6
Total Current Liabilities 3,020.2 2,381.5
Deferred income taxes, net 1,101.5 3,030.9
Long-term income tax payable 744.0 473.7
Other long-term liabilities 445.8 462.6
Long-term debt 8,917.5 10,665.8
Total Liabilities 14,229.0 17,014.5
Commitments and Contingencies (Note 19)
Stockholders' Equity:    
Common stock, $0.01 par value, one billion shares authorized, 306.5 million (304.7 million in 2016) issued 3.1 3.1
Paid-in capital 8,514.9 8,368.5
Retained earnings 10,022.8 8,467.1
Accumulated other comprehensive loss (83.2) (434.0)
Treasury stock, 103.9 million shares (104.1 million shares in 2016) (6,721.8) (6,735.8)
Total Zimmer Biomet Holdings, Inc. stockholders' equity 11,735.8 9,668.9
Noncontrolling interest (0.3) 1.0
Total Stockholders' Equity 11,735.5 9,669.9
Total Liabilities and Stockholders' Equity $ 25,964.5 $ 26,684.4